Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2019-003319-76Phase 4Completed
Phase 4, randomised, double-blind trial of ropivacaine and sufentanil in labor pain (2 arms), sponsored by UZ Leuven. Primary endpoint: Breakthrough pain. Started Aug 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2019-003319-76.